it is drug product with API and 5 other excipients.
the API peak area is not decreasing as time goes by.
It is hard to tell. PDA RRT 0.8 looks not competely alike API, but a bit similar.
The sample prep is as following:
lyophilized sample + acetate buffer, then dilute with 100% methanol.
for API and bulk solution, dilute with 100% methanol directly.
With the same kind of sample preparation (100% methanol):
This RRT 0.8 is not in API (acetate buffer is not involved here)
it is not in bulk active solution (before the lyophilization) (acetate buffer is not involved here)
it is not in bulk placebo solution (before the lyophilization) (acetate buffer is not involved here)
it is not in lyophilized placebo (acetate buffer is involved here).
it is in the lyophilized active (acetate buffer is involved here), and it grows with the extraction time.
It is not stability temperature dependent.
if this impurity is real. it is lyophilization dependent. (can not rule out acetate buffer effect). and it is extraction time dependent.
How do I know it is the solubility but not the solution stability?
Can I filter the reconstituted lyophilized active solution, and then monitor the assay and impurity?